Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Each test can be performed with merely half a drop of blood.
Galleri is the first of a wave of multi-cancer early-detection tests that analyze DNA fragments in the blood for abnormalities.
Researchers are testing the reliability of a blood-based test, a preferable screening method for a variety of preventive tests.
A research team believes fragmentomics has several advantages when it comes to liquid biopsies for cancer detection.
Risk-based testing alone has failed to identify a majority of people living with chronic HBV.
Patients whose treatment was guided by measurement of tumor cells in the blood had improved survival outcomes.
New tests can detect a common signal across more than 50 types of cancer from tumor DNA in blood.
As a survivor, I feel I must spread awareness and hopefully inspiration to people I come in contact with.
Stage3b colorectal cancer survivor, Joe Bullock, shares how his journey has inspired him to become an advocate
Guardant Health’s LUNAR2 blood test detected 90% of colorectal cancer in asymptomatic individuals in a retrospective study.
Improved detection methods could make a world of difference for patients undergoing cancer therapy.
The test can detect more than 50 cancers, including many that are difficult to catch early, with very few false positives.
Mixed-size DNA fragments in a blood sample may predict residual cancer as well as MRI scans.
A personalized blood test can detect colon cancer recurrence sooner than scans.
Tests for circulating tumor DNA can help predict which patients are more likely to relapse.
In the midst of his testicular cancer journey, Anthony Mastrogiulio found his cancer family.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.